134 related articles for article (PubMed ID: 16330000)
1. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
Garcia RA; Liu L; Hu Z; Gonzalez A; von Borstel RW; Saydoff JA
Brain Res; 2005 Dec; 1066(1-2):164-71. PubMed ID: 16330000
[TBL] [Abstract][Full Text] [Related]
2. Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.
Saydoff JA; Liu LS; Garcia RA; Hu Z; Li D; von Borstel RW
Brain Res; 2003 Dec; 994(1):44-54. PubMed ID: 14642447
[TBL] [Abstract][Full Text] [Related]
3. Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models.
Saydoff JA; Olariu A; Sheng J; Hu Z; Li Q; Garcia R; Pei J; Sun GY; von Borstel R
J Alzheimers Dis; 2013; 36(4):637-57. PubMed ID: 23648515
[TBL] [Abstract][Full Text] [Related]
4. Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease.
Saydoff JA; Garcia RA; Browne SE; Liu L; Sheng J; Brenneman D; Hu Z; Cardin S; Gonzalez A; von Borstel RW; Gregorio J; Burr H; Beal MF
Neurobiol Dis; 2006 Dec; 24(3):455-65. PubMed ID: 17011205
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
6. Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells.
González-Aragón D; Ariza J; Villalba JM
Biochem Pharmacol; 2007 Feb; 73(3):427-39. PubMed ID: 17123468
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.
Katsafanas GC; Grem JL; Blough HA; Moss B
Virology; 1997 Sep; 236(1):177-87. PubMed ID: 9299630
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
Chan TC; Howell SB
Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
10. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
Karle JM; Anderson LW; Dietrick DD; Cysyk RL
Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartate.
Wiley RG; Gralla RJ; Casper ES; Kemeny N
Ann Neurol; 1982 Aug; 12(2):175-83. PubMed ID: 7125606
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based model for tumor drug resistance.
Kuczek T; Chan TC
Cancer Chemother Pharmacol; 1992; 30(5):355-9. PubMed ID: 1505073
[TBL] [Abstract][Full Text] [Related]
13. Salvage of circulating pyrimidine nucleosides in the rat.
Moyer JD; Oliver JT; Handschumacher RE
Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957
[TBL] [Abstract][Full Text] [Related]
14. Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells.
Jacobsen LB; Putnam JE; Sawick DP; Cassady JM; Morré DJ
Life Sci; 1988; 42(8):913-8. PubMed ID: 3343891
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-protein diet on pyrimidine synthesis and response to PALA in mouse tissues.
Zaharevitz DW; Grubb MF; Hyman R; Chisena C; Cysyk RL
J Natl Cancer Inst; 1993 Apr; 85(8):662-6. PubMed ID: 8468725
[TBL] [Abstract][Full Text] [Related]
16. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
[TBL] [Abstract][Full Text] [Related]
17. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole.
Tessera L; Mucciolo E; Bertoni L; Giulotto E
Anticancer Res; 1995; 15(1):189-92. PubMed ID: 7733632
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
[TBL] [Abstract][Full Text] [Related]
19. Brain pyrimidine nucleotide synthesis and Alzheimer disease.
Pesini A; Iglesias E; Bayona-Bafaluy MP; Garrido-Pérez N; Meade P; Gaudó P; Jiménez-Salvador I; Andrés-Benito P; Montoya J; Ferrer I; Pesini P; Ruiz-Pesini E
Aging (Albany NY); 2019 Sep; 11(19):8433-8462. PubMed ID: 31560653
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.
Karle JM; Anderson LW; Cysyk RL
J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
